Immunotherapy breakthrough: Pembrolizumab extends time to recurrence in aggressive bladder cancer

https://www.news-medical.net/news/20240127/Immunotherapy-breakthrough-Pembrolizumab-extends-time-to-recurrence-in-aggressive-bladder-cancer.aspx